Carolina Corcho denies Invima about the purchase of scarce medicines

At the beginning of March, the Colombian Association of Comprehensive Medicine Companies warned of a drug crisis in the country. According to the union, there are several drugs for different ailments that are in short supply.

(Also read: Drug shortages are a polarized debate: director of Invima).

Faced with the issue, the director of Invima, Francisco Rossi, assured that the health minister, Carolina Corcho, has received several requests from laboratories for the importation of out-of-supply products.

Related topics


“List in hand they tell us: ‘this is out of stock, I’ll put it in a week in Bogotá, in a container at a minimum price,’ Rossi said, this March 15, during a debate on political control in Congress.

According to Rossi, the ministry does not consider that importing medicines from abroad is the solution to the shortage of medicines, even more so, “in a country like Colombia that wants to strengthen industrialization.”

However, this Sunday Minister Corcho denied the statements of the director of Invima and clarified that she has not received any offer from any laboratory international to resolve to face the contingency.

“I have not held a meeting with any international laboratory that has offered medicines that are in short supply. There is no container waiting for input. The Ministry of Health can be a facilitator, but it is not the buyer of these medicines that corresponds to other agents in the system, ”Corcho explained on his Twitter account.

In addition, she mentioned that they have developed more than 10 technical tables to solve this problem that the country has been facing for, according to her, more than four years ago.

“We have developed more than 10 technical tables to resolve each case in the face of a phenomenon that is global and has been in Colombia for more than 4 years. Inspection, surveillance, and control bodies were asked to inquire regarding information from agents, since they do not report to @MinSaludCol,” concluded the portfolio manager.

ELTIEMPO.COM

Leave a Replay